Company Profile
Updated: 17-SEP-09Bioenvision Inc.
Private Company, Headquarters Location
345 Park Ave., 41St. Fl., New York, NY 10154-0004, United States
(212)750-6700, (212)750-6777 fax, http://www.bioenvision.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Developing and aquiring oncology drugs.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Reportlinker Adds Reinforced Plastics - A Global Market Report.
PR Newswire; 12/8/2009; 2069 words; ...Market Report" by BizAcumen, Inc. Our reports are designed to...microbial Technology from Bioenvision 13 Saint-Gobain and Owens...5. MAJOR PLAYERS 17 AZDEL, Inc. (USA) 17 Composite Products, Inc. (USA) 17 Foster Corporation...
Research and Markets: Reinforced Plastics - a Global Market Report: the Most Comprehensive in Geographic Coverage and Vertical Market Analyses.
Business Wire; 11/27/2009; 1079 words; ...Market Report" by BizAcumen, Inc. This report is designed to...microbial Technology from Bioenvision * Saint-Gobain and Owens Corning...Province MAJOR PLAYERS * AZDEL, Inc. (USA) * Composite Products, Inc. (USA) * Foster Corporation...
No Relief for Genzyme as APB Failure Dents Renal Franchise.
BIOWORLD Today; 11/19/2009; 1583 words; ...AstraZeneca plc) and ImClone Systems Inc. (by Eli Lilly & Co.), though attempts at putting Biogen Idec Inc. on the selling block have so far...buyout of partner New York-based Bioenvision Inc. two years ago. (See BioWorld...
Other News To Note.
BIOWORLD Today; 11/4/2009; 3715 words; ...funding and milestone payments. Bioenvision Inc., of New York, established its...Complementing an office in London, Bioenvision said the new office allows it to...and technology program. Cephalon Inc., of West Chester, Pa., said...
Bioenvision Brings In $17.8M For Trials Of Two Cancer Drugs.
BIOWORLD Today; 11/4/2009; 806 words; Staff Writer Bioenvision Inc. completed a private placement...Modrenal. New York-based Bioenvision sold shares at $1.50 each...is being co-developed with Bioenvision partner Ilex Oncology Inc., of San Antonio. Clofarabine...
Recent News Articles
- Q4 2007 BIOENVISION INC Earnings Conference Call - Final.
Fair Disclosure Wire - September 12, 2007 - Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.
PR Newswire - July 27, 2007 - Bioenvision, Inc. Says Securities Class Action Litigation Without Merit.
Business Wire - July 26, 2007 - Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.
PR Newswire - July 10, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning